Parents of children with eczema are more likely to be short on sleep and to use medication to try to get more of it, a retrospective National Health Interview Survey (NHIS) analysis showed. In a ...

A study revealed that parents of children with atopic dermatitis experience less than optimal sleep and are more reliant on ...

Onset under the age of 2 years (not used in children below the age of 4 years). Data taken from reference 54. The incidence of atopic dermatitis has increased two- to threefold in industrialized ...

The following is a summary of “Skin Microbiome in the First Year of Life and Its Association With Atopic Dermatitis,” ...

Atopic dermatitis, which many people call eczema ... and environmental factors. While most children can grow out of it, some of them will experience flare-ups throughout their lives.

The US FDA has approved Vtama 1% cream for the topical treatment of atopic dermatitis in adult and pediatric patients aged 2 ...

Annual Meeting took place in Toronto, Canada, July 11-15, with our top coverage including the hot topics of combating ...

Technoderma Medicines, Inc. ('the Company'), a clinical stage biopharmaceutical company, is pleased to report the Company has completed its Phase 2a clinical trial (NCT06363461) of topical TDM-180935 ...

FDA experts report changes in drug approvals, warnings, and indications for products for use by dermatologists and aesthetic medicine professionals.

Stapokibart (Kangyueda) is a humanized monoclonal antibody. It is formulated as a solution for the subcutaneous route of administration. Kangyueda is indicated for the treatment of moderate to severe ...

For some people, keeping up with eczema treatments can be difficult, but resources are available to help find relief from the ...

Zoryve is under clinical development by Arcutis Biotherapeutics and currently in Pre-Registration for Psoriasis.